1 Study Coverage 1.1 Femoral Venous Cannulae Product Introduction 1.2 Global Femoral Venous Cannulae Outlook 2017 VS 2022 VS 2028 1.2.1 Global Femoral Venous Cannulae Sales in US$ Million for the Year 2017-2028 1.2.2 Global Femoral Venous Cannulae Sales in Volume for the Year 2017-2028 1.3 United States Femoral Venous Cannulae Outlook 2017 VS 2022 VS 2028 1.3.1 United States Femoral Venous Cannulae Sales in US$ Million for the Year 2017-2028 1.3.2 United States Femoral Venous Cannulae Sales in Volume for the Year 2017-2028 1.4 Femoral Venous Cannulae Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Femoral Venous Cannulae in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Femoral Venous Cannulae Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Femoral Venous Cannulae Market Dynamics 1.5.1 Femoral Venous Cannulae Industry Trends 1.5.2 Femoral Venous Cannulae Market Drivers 1.5.3 Femoral Venous Cannulae Market Challenges 1.5.4 Femoral Venous Cannulae Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Femoral Venous Cannulae Market Segment by Type 2.1.1 Single-stage 2.1.2 Two-stage 2.2 Global Femoral Venous Cannulae Market Size by Type 2.2.1 Global Femoral Venous Cannulae Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Femoral Venous Cannulae Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Femoral Venous Cannulae Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Femoral Venous Cannulae Market Size by Type 2.3.1 United States Femoral Venous Cannulae Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Femoral Venous Cannulae Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Femoral Venous Cannulae Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Femoral Venous Cannulae Market Segment by Application 3.1.1 Hospitals 3.1.2 Ambulatory Surgical Centers (ASC) 3.1.3 Others 3.2 Global Femoral Venous Cannulae Market Size by Application 3.2.1 Global Femoral Venous Cannulae Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Femoral Venous Cannulae Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Femoral Venous Cannulae Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Femoral Venous Cannulae Market Size by Application 3.3.1 United States Femoral Venous Cannulae Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Femoral Venous Cannulae Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Femoral Venous Cannulae Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Femoral Venous Cannulae Competitor Landscape by Company 4.1 Global Femoral Venous Cannulae Market Size by Company 4.1.1 Top Global Femoral Venous Cannulae Manufacturers Ranked by Revenue (2021) 4.1.2 Global Femoral Venous Cannulae Revenue by Manufacturer (2017-2022) 4.1.3 Global Femoral Venous Cannulae Sales by Manufacturer (2017-2022) 4.1.4 Global Femoral Venous Cannulae Price by Manufacturer (2017-2022) 4.2 Global Femoral Venous Cannulae Concentration Ratio (CR) 4.2.1 Femoral Venous Cannulae Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Femoral Venous Cannulae in 2021 4.2.3 Global Femoral Venous Cannulae Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Femoral Venous Cannulae Manufacturing Base Distribution, Product Type 4.3.1 Global Femoral Venous Cannulae Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Femoral Venous Cannulae Product Type 4.3.3 Date of International Manufacturers Enter into Femoral Venous Cannulae Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Femoral Venous Cannulae Market Size by Company 4.5.1 Top Femoral Venous Cannulae Players in United States, Ranked by Revenue (2021) 4.5.2 United States Femoral Venous Cannulae Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Femoral Venous Cannulae Sales by Players (2020, 2021 & 2022) 5 Global Femoral Venous Cannulae Market Size by Region 5.1 Global Femoral Venous Cannulae Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Femoral Venous Cannulae Market Size in Volume by Region (2017-2028) 5.2.1 Global Femoral Venous Cannulae Sales in Volume by Region: 2017-2022 5.2.2 Global Femoral Venous Cannulae Sales in Volume Forecast by Region (2023-2028) 5.3 Global Femoral Venous Cannulae Market Size in Value by Region (2017-2028) 5.3.1 Global Femoral Venous Cannulae Sales in Value by Region: 2017-2022 5.3.2 Global Femoral Venous Cannulae Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Femoral Venous Cannulae Market Size YoY Growth 2017-2028 6.1.2 North America Femoral Venous Cannulae Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Femoral Venous Cannulae Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Femoral Venous Cannulae Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Femoral Venous Cannulae Market Size YoY Growth 2017-2028 6.3.2 Europe Femoral Venous Cannulae Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Femoral Venous Cannulae Market Size YoY Growth 2017-2028 6.4.2 Latin America Femoral Venous Cannulae Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Femoral Venous Cannulae Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Femoral Venous Cannulae Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Medtronic 7.1.1 Medtronic Corporation Information 7.1.2 Medtronic Description and Business Overview 7.1.3 Medtronic Femoral Venous Cannulae Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Medtronic Femoral Venous Cannulae Products Offered 7.1.5 Medtronic Recent Development 7.2 Edward Lifescience 7.2.1 Edward Lifescience Corporation Information 7.2.2 Edward Lifescience Description and Business Overview 7.2.3 Edward Lifescience Femoral Venous Cannulae Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Edward Lifescience Femoral Venous Cannulae Products Offered 7.2.5 Edward Lifescience Recent Development 7.3 LivaNova 7.3.1 LivaNova Corporation Information 7.3.2 LivaNova Description and Business Overview 7.3.3 LivaNova Femoral Venous Cannulae Sales, Revenue and Gross Margin (2017-2022) 7.3.4 LivaNova Femoral Venous Cannulae Products Offered 7.3.5 LivaNova Recent Development 7.4 Surge Cardiovascular 7.4.1 Surge Cardiovascular Corporation Information 7.4.2 Surge Cardiovascular Description and Business Overview 7.4.3 Surge Cardiovascular Femoral Venous Cannulae Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Surge Cardiovascular Femoral Venous Cannulae Products Offered 7.4.5 Surge Cardiovascular Recent Development 7.5 KangXin Medical 7.5.1 KangXin Medical Corporation Information 7.5.2 KangXin Medical Description and Business Overview 7.5.3 KangXin Medical Femoral Venous Cannulae Sales, Revenue and Gross Margin (2017-2022) 7.5.4 KangXin Medical Femoral Venous Cannulae Products Offered 7.5.5 KangXin Medical Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Femoral Venous Cannulae Industry Chain Analysis 8.2 Femoral Venous Cannulae Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Femoral Venous Cannulae Distributors 8.3 Femoral Venous Cannulae Production Mode & Process 8.4 Femoral Venous Cannulae Sales and Marketing 8.4.1 Femoral Venous Cannulae Sales Channels 8.4.2 Femoral Venous Cannulae Distributors 8.5 Femoral Venous Cannulae Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Femoral Venous Cannulae CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Femoral Venous Cannulae Market Trends Table 3. Femoral Venous Cannulae Market Drivers Table 4. Femoral Venous Cannulae Market Challenges Table 5. Femoral Venous Cannulae Market Restraints Table 6. Global Femoral Venous Cannulae Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Femoral Venous Cannulae Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Femoral Venous Cannulae Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Femoral Venous Cannulae Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Femoral Venous Cannulae Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Femoral Venous Cannulae Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Femoral Venous Cannulae Revenue Share by Manufacturer, 2017-2022 Table 13. Global Femoral Venous Cannulae Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Femoral Venous Cannulae Sales Share by Manufacturer, 2017-2022 Table 15. Global Femoral Venous Cannulae Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Femoral Venous Cannulae Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Femoral Venous Cannulae by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Femoral Venous Cannulae as of 2021) Table 18. Top Players of Femoral Venous Cannulae in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Femoral Venous Cannulae Product Type Table 20. Date of International Manufacturers Enter into Femoral Venous Cannulae Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Femoral Venous Cannulae Players in United States Market, Ranking by Revenue (2021) Table 23. United States Femoral Venous Cannulae Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Femoral Venous Cannulae Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Femoral Venous Cannulae Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Femoral Venous Cannulae Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Femoral Venous Cannulae Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Femoral Venous Cannulae Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Femoral Venous Cannulae Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Femoral Venous Cannulae Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Femoral Venous Cannulae Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Femoral Venous Cannulae Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Femoral Venous Cannulae Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Femoral Venous Cannulae Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Femoral Venous Cannulae Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Femoral Venous Cannulae Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Femoral Venous Cannulae Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Femoral Venous Cannulae Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Femoral Venous Cannulae Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Femoral Venous Cannulae Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Femoral Venous Cannulae Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Medtronic Corporation Information Table 43. Medtronic Description and Business Overview Table 44. Medtronic Femoral Venous Cannulae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Medtronic Femoral Venous Cannulae Product Table 46. Medtronic Recent Development Table 47. Edward Lifescience Corporation Information Table 48. Edward Lifescience Description and Business Overview Table 49. Edward Lifescience Femoral Venous Cannulae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Edward Lifescience Product Table 51. Edward Lifescience Recent Development Table 52. LivaNova Corporation Information Table 53. LivaNova Description and Business Overview Table 54. LivaNova Femoral Venous Cannulae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. LivaNova Product Table 56. LivaNova Recent Development Table 57. Surge Cardiovascular Corporation Information Table 58. Surge Cardiovascular Description and Business Overview Table 59. Surge Cardiovascular Femoral Venous Cannulae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Surge Cardiovascular Product Table 61. Surge Cardiovascular Recent Development Table 62. KangXin Medical Corporation Information Table 63. KangXin Medical Description and Business Overview Table 64. KangXin Medical Femoral Venous Cannulae Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. KangXin Medical Product Table 66. KangXin Medical Recent Development Table 67. Key Raw Materials Lists Table 68. Raw Materials Key Suppliers Lists Table 69. Femoral Venous Cannulae Customers List Table 70. Femoral Venous Cannulae Distributors List Table 71. Research Programs/Design for This Report Table 72. Key Data Information from Secondary Sources Table 73. Key Data Information from Primary Sources List of Figures Figure 1. Femoral Venous Cannulae Product Picture Figure 2. Global Femoral Venous Cannulae Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Femoral Venous Cannulae Market Size 2017-2028 (US$ Million) Figure 4. Global Femoral Venous Cannulae Sales 2017-2028 (K Units) Figure 5. United States Femoral Venous Cannulae Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Femoral Venous Cannulae Market Size 2017-2028 (US$ Million) Figure 7. United States Femoral Venous Cannulae Sales 2017-2028 (K Units) Figure 8. United States Femoral Venous Cannulae Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Femoral Venous Cannulae Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Femoral Venous Cannulae Report Years Considered Figure 11. Product Picture of Single-stage Figure 12. Product Picture of Two-stage Figure 13. Global Femoral Venous Cannulae Market Share by Type in 2022 & 2028 Figure 14. Global Femoral Venous Cannulae Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Femoral Venous Cannulae Sales Market Share in Value by Type (2017-2028) Figure 16. Global Femoral Venous Cannulae Sales by Type (2017-2028) & (K Units) Figure 17. Global Femoral Venous Cannulae Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Femoral Venous Cannulae Price by Type (2017-2028) & (US$/Unit) Figure 19. United States Femoral Venous Cannulae Market Share by Type in 2022 & 2028 Figure 20. United States Femoral Venous Cannulae Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Femoral Venous Cannulae Sales Market Share in Value by Type (2017-2028) Figure 22. United States Femoral Venous Cannulae Sales by Type (2017-2028) & (K Units) Figure 23. United States Femoral Venous Cannulae Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Femoral Venous Cannulae Price by Type (2017-2028) & (US$/Unit) Figure 25. Product Picture of Hospitals Figure 26. Product Picture of Ambulatory Surgical Centers (ASC) Figure 27. Product Picture of Others Figure 28. Global Femoral Venous Cannulae Market Share by Application in 2022 & 2028 Figure 29. Global Femoral Venous Cannulae Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Femoral Venous Cannulae Sales Market Share in Value by Application (2017-2028) Figure 31. Global Femoral Venous Cannulae Sales by Application (2017-2028) & (K Units) Figure 32. Global Femoral Venous Cannulae Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Femoral Venous Cannulae Price by Application (2017-2028) & (US$/Unit) Figure 34. United States Femoral Venous Cannulae Market Share by Application in 2022 & 2028 Figure 35. United States Femoral Venous Cannulae Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Femoral Venous Cannulae Sales Market Share in Value by Application (2017-2028) Figure 37. United States Femoral Venous Cannulae Sales by Application (2017-2028) & (K Units) Figure 38. United States Femoral Venous Cannulae Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Femoral Venous Cannulae Price by Application (2017-2028) & (US$/Unit) Figure 40. North America Femoral Venous Cannulae Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Femoral Venous Cannulae Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. United States Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Femoral Venous Cannulae Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Femoral Venous Cannulae Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Femoral Venous Cannulae Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Femoral Venous Cannulae Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. China Taiwan Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Femoral Venous Cannulae Sales in Volume Growth Rate 2017-2028 (K Units) Figure 63. Latin America Femoral Venous Cannulae Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Femoral Venous Cannulae Sales in Volume Growth Rate 2017-2028 (K Units) Figure 68. Middle East & Africa Femoral Venous Cannulae Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. UAE Femoral Venous Cannulae Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Femoral Venous Cannulae Value Chain Figure 73. Femoral Venous Cannulae Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Medtronic Edward Lifescience LivaNova Surge Cardiovascular KangXin Medical